Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.

Proc Natl Acad Sci U S A · 2022 · PMC9060444 · PMID 35312359

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

1 A and B ), exhibited a relative survival of 0.03, 15-fold higher than control, but this difference did not reach statistical significance ( Fig. 5 , green).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.